Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses
- PMID: 33053338
- DOI: 10.1016/j.celrep.2020.108263
Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses
Abstract
The advent of induced pluripotent stem cell (iPSC)-derived neurons has revolutionized Parkinson's disease (PD) research, but single-cell transcriptomic analysis suggests unresolved cellular heterogeneity within these models. Here, we perform the largest single-cell transcriptomic study of human iPSC-derived dopaminergic neurons to elucidate gene expression dynamics in response to cytotoxic and genetic stressors. We identify multiple neuronal subtypes with transcriptionally distinct profiles and differential sensitivity to stress, highlighting cellular heterogeneity in dopamine in vitro models. We validate this disease model by showing robust expression of PD GWAS genes and overlap with postmortem adult substantia nigra neurons. Importantly, stress signatures are ameliorated using felodipine, an FDA-approved drug. Using isogenic SNCA-A53T mutants, we find perturbations in glycolysis, cholesterol metabolism, synaptic signaling, and ubiquitin-proteasomal degradation. Overall, our study reveals cell type-specific perturbations in human dopamine neurons, which will further our understanding of PD and have implications for cell replacement therapies.
Keywords: Cholesterol biosynthesis; Dopamine neurons; ER stress; Felodipine; Human iPSC; Oxidative stress; PD GWAS; Parkinson's disease; SNCA-A53T; Single-cell transcriptomics.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Similar articles
-
Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.Cell Stem Cell. 2019 Jan 3;24(1):93-106.e6. doi: 10.1016/j.stem.2018.10.023. Epub 2018 Nov 29. Cell Stem Cell. 2019. PMID: 30503143 Free PMC article.
-
Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.Parkinsonism Relat Disord. 2016 Mar;24:81-8. doi: 10.1016/j.parkreldis.2016.01.001. Epub 2016 Jan 6. Parkinsonism Relat Disord. 2016. PMID: 26797011
-
Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.Hum Mol Genet. 2019 Jun 15;28(12):2001-2013. doi: 10.1093/hmg/ddz038. Hum Mol Genet. 2019. PMID: 30753527 Free PMC article.
-
Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.J Parkinsons Dis. 2018;8(4):479-493. doi: 10.3233/JPD-181353. J Parkinsons Dis. 2018. PMID: 30149462 Free PMC article. Review.
-
Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.Biochem Soc Trans. 2013 Dec;41(6):1503-8. doi: 10.1042/BST20130194. Biochem Soc Trans. 2013. PMID: 24256244 Review.
Cited by
-
Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models.Front Neurol. 2022 Jan 25;12:786835. doi: 10.3389/fneur.2021.786835. eCollection 2021. Front Neurol. 2022. PMID: 35145469 Free PMC article. Review.
-
Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.Cells. 2024 Apr 25;13(9):745. doi: 10.3390/cells13090745. Cells. 2024. PMID: 38727281 Free PMC article. Review.
-
Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells.Neuropsychopharmacol Rep. 2023 Sep;43(3):440-445. doi: 10.1002/npr2.12361. Epub 2023 Jun 27. Neuropsychopharmacol Rep. 2023. PMID: 37366076 Free PMC article.
-
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease.Adv Sci (Weinh). 2024 Nov;11(41):e2403105. doi: 10.1002/advs.202403105. Epub 2024 Sep 16. Adv Sci (Weinh). 2024. PMID: 39279468 Free PMC article.
-
Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer's disease dataset.Elife. 2023 Dec 4;12:RP90214. doi: 10.7554/eLife.90214. Elife. 2023. PMID: 38047913 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous